CareDx, Inc (CDNA) vs Tango Therapeutics, Inc. (TNGX)

A side-by-side comparison of CareDx, Inc and Tango Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CDNA vs TNGX

growth of $100 · dividends reinvested · last 6y
CDNA +103.5% (+12.6%/yr)TNGX +125.6% (+14.5%/yr)TNGX compounded faster over this window
0100200300Start $100202120222023202420252026$203$226
CDNA TNGX

CDNA vs TNGX: by the numbers

  • •TNGX is the larger company ($3.57B vs $3.30B market cap).
  • •CDNA is profitable (24.23% net margin) while TNGX runs a net loss (-229.92%).
  • •TNGX grew revenue faster over the past five years (19.14% vs 12.56% CAGR).

Metrics side by side

Valuation

MetricCDNATNGX
P/E ratio30.80N/A
Forward P/E53.26N/A
P/S ratio7.2066.26
P/B ratio7.753.48
EV / EBITDA189.34N/A
FCF yield2.58%N/A

Profitability

MetricCDNATNGX
Gross margin70.58%98.25%
Operating margin-0.92%-178.39%
Net margin24.23%-229.92%
ROE26.08%-12.08%
ROIC-0.93%-12.91%

Growth (annualized)

MetricCDNATNGX
Revenue CAGR (5Y)12.56%19.14%
Total return CAGR (5Y)1.33%10.60%

Frequently asked

Which has grown faster, CDNA or TNGX?
Over the past five years, TNGX grew revenue faster — CDNA at a 12.56% CAGR versus TNGX at 19.14%.
Is CDNA or TNGX more profitable?
CDNA runs the higher net margin — CDNA at 24.23% versus TNGX at -229.92%.
How have CDNA and TNGX total returns compared?
Over the past 5 years, CDNA delivered 1.33% and TNGX delivered 10.60% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.